I agree that this site is using cookies. You can find further informations here.
X
Gamez, Josep
138  results:
OpenAccess-fulltext X
?
1

Long-term efficacy and safety of inotersen for hereditary t..:

Brannagan, Thomas H ; Coelho, Teresa ; Wang, Annabel K...
10.1007/s00415-022-11276-8.  , 2022
Link: https://hdl.handle.net/1..
 
?
2

Dystrophinopathy Phenotypes and Modifying Factors in Exon 4..:

Poyatos-García, Javier ; Martí, Pilar ; Liquori, Alessandro...
Ministerio de Economía y Competitividad PI16/00316.  , 2022
Link: https://ddd.uab.cat/reco..
 
?
3

Dystrophinopathy Phenotypes and Modifying Factors in DMD Ex..:

Poyatos‐García, Javier ; Martí, Pilar ; Liquori, Alessandro...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825930/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
4

Long-term efficacy and safety of inotersen for hereditary t..:

Brannagan, Thomas H ; Coelho, Teresa ; Wang, Annabel K...
https://www.springer.com/journal/415.  , 2022
Link: http://hdl.handle.net/10..
 
?
5

Long-term efficacy and safety of inotersen for hereditary t..:

Brannagan, Thomas H ; Coelho, Teresa ; Wang, Annabel K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618524/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

Randomized phase 2 study of ACE-083, a muscle-promoting age..:

Statland, Jeffrey M ; Campbell, Craig ; Desai, Urvi...
10.1002/mus.27558.  , 2022
Link: https://hdl.handle.net/1..
 
?
7

Randomized phase 2 study of ACE-083, a muscle-promoting age..:

Statland, Jeffrey ; Campbell, Craig ; Desai, Urvi...
qt4rb044kb.  , 2022
Link: https://escholarship.org..
 
?
8

Cognitive decline in amyotrophic lateral sclerosis : Neurop..:

Borrego-Écija, Sergi ; Turon-Sans, Janina ; Ximelis, Teresa...
Ministerio de Economía, Industria y Competitividad PI16/01673.  , 2021
Link: https://ddd.uab.cat/reco..
 
?
9

Variably protease-sensitive prionopathy presenting within A..:

Vicente-Pascual, Mikel ; Rossi, Marcello ; Gámez, Josep...
Reproducció del document publicat a https://doi.org/10.1002/acn3.632.  , 2021
Link: http://hdl.handle.net/10..
 
?
10

Long-term survival analysis of masitinib in amyotrophic lat..:

Mora, Jesus S ; Bradley, Walter G ; Chaverri, Delia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388186/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

Cognitive decline in amyotrophic lateral sclerosis: Neuropa..:

Borrego Écija, Sergi ; Turon Sans, Janina ; Ximelis, Teresa...
Reproducció del document publicat a: https://doi.org/10.1111/bpa.12942.  , 2021
Link: http://hdl.handle.net/24..
 
?
12

Early data on long‐term efficacy and safety of inotersen in..:

Brannagan, T. H ; Wang, A. K ; Coelho, T...
https://onlinelibrary.wiley.com/doi/10.1111/ene.14285.  , 2020
Link: http://hdl.handle.net/10..
 
?
13

Masitinib as an add-on therapy to riluzole in patients with..:

Mora, J. S ; Genge, A ; Chiò, Adriano...
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.  , 2020
Link: https://ddd.uab.cat/reco..
 
?
14

Intravenous immunoglobulin to prevent myasthenic crisis aft..:

Gamez, Josep ; Salvadó, Maria ; Carmona, Francesc...
Therapeutic Advances in Neurological Disorders.  , 2019
Link: https://ddd.uab.cat/reco..
 
?
15

Intravenous immunoglobulin to prevent myasthenic crisis aft..:

Gamez, Josep ; Salvadó, María ; Carmona, Francesc...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640060/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
1-15